Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation

In 2007, we conducted a prospective randomized study to compare an aggressive dose escalation (group B, n = 123) with the standard dose escalation proposed by European LeukemiaNet (group A, n = 122). In group B, if patients did not achieve a complete cytogenetic response (CCyR) at 3 months or did no...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood Adv
Hauptverfasser: Miyamura, Koichi, Ohnishi, Kazunori, Ohtake, Shigeki, Usui, Noriko, Nakaseko, Chiaki, Fujita, Hiroyuki, Fujisawa, Shin, Sakura, Toru, Okumura, Hirokazu, Iriyama, Noriyoshi, Emi, Nobuhiko, Fujimaki, Katsumichi, Honda, Sumihisa, Miyazaki, Yasushi, Naoe, Tomoki
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2019
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6373759/
https://ncbi.nlm.nih.gov/pubmed/30705033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018025981
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge